These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17126795)

  • 21. Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice.
    Chijiwa T; Abe Y; Ikoma N; Yamazaki H; Tsukamoto H; Suemizu H; Kawai K; Wakui M; Nishime C; Matsumoto H; Matsuyama M; Mukai M; Ueyama Y; Nakamura M
    Int J Oncol; 2009 Jan; 34(1):5-13. PubMed ID: 19082472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of plasminogen activator inhibitor type 1 on apoptosis.
    Schneider DJ; Chen Y; Sobel BE
    Thromb Haemost; 2008 Dec; 100(6):1037-40. PubMed ID: 19132227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Games network and application to PAs system.
    Chettaoui C; Delaplace F; Manceny M; Malo M
    Biosystems; 2007 Feb; 87(2-3):136-41. PubMed ID: 17070987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells.
    Yao K; Tan J; Ye P; Wang K; Xu W; ShenTu X; Tang X
    Mol Vis; 2007 Sep; 13():1769-76. PubMed ID: 17960115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
    Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
    Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ
    Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression.
    Lamy PJ; Verjat T; Servanton AC; Paye M; Leissner P; Mougin B
    Am J Clin Pathol; 2007 Sep; 128(3):404-13. PubMed ID: 17709314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
    Offersen BV; Pfeiffer P; Andreasen P; Overgaard J
    Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical modelling of cancer cell invasion of tissue: local and non-local models and the effect of adhesion.
    Gerisch A; Chaplain MA
    J Theor Biol; 2008 Feb; 250(4):684-704. PubMed ID: 18068728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines.
    Roger S; Rollin J; Barascu A; Besson P; Raynal PI; Iochmann S; Lei M; Bougnoux P; Gruel Y; Le Guennec JY
    Int J Biochem Cell Biol; 2007; 39(4):774-86. PubMed ID: 17307016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polarity proteins in migration and invasion.
    Etienne-Manneville S
    Oncogene; 2008 Nov; 27(55):6970-80. PubMed ID: 19029938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer.
    Offersen BV; Riisbro R; Knoop A; Brünner N; Overgaard J;
    Acta Oncol; 2007; 46(6):782-91. PubMed ID: 17653901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of ephrins in regulation of tumour cell migration].
    Wybieralska E; Łaczna E; Madeja Z
    Postepy Biochem; 2009; 55(2):153-62. PubMed ID: 19824471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.
    Iwadate Y; Hayama M; Adachi A; Matsutani T; Nagai Y; Hiwasa T; Saeki N
    Anticancer Res; 2008; 28(1B):415-8. PubMed ID: 18383878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alteration of plasminogen activator inhibitor-1 expression by linoleic acid and fenofibrate in HepG2 cells.
    Ye P; He YL; Wang Q; Liu YX
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):15-9. PubMed ID: 17179821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.